Hutchison Medipharma Limited
Clinical trials sponsored by Hutchison Medipharma Limited, explained in plain language.
-
New combo shows promise for tough stomach cancer
Disease control CompletedThis study tested a new combination of two drugs (fruquintinib and paclitaxel) in 703 people with advanced stomach cancer that had gotten worse after initial treatment. The goal was to see if the combo could help people live longer and slow the cancer's growth compared to paclita…
Phase: PHASE3 • Sponsor: Hutchison Medipharma Limited • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
New hope for stomach cancer patients with MET gene changes
Disease control CompletedThis study tested a drug called savolitinib in 110 adults with advanced stomach or esophagus-stomach junction cancer whose tumors have a specific gene change (MET amplification). The goal was to see if the drug could shrink tumors and how safe it was. Participants received savoli…
Phase: PHASE2 • Sponsor: Hutchison Medipharma Limited • Aim: Disease control
Last updated May 14, 2026 12:03 UTC